Keyphrases
Antenatal Steroids
25%
Cerebral Palsy
100%
Cerebral Palsy children
25%
Chronic Lung Disease
50%
Confidence Interval
75%
Developmental Delay
50%
Dexamethasone Treatment
100%
Early Postnatal
100%
Follow-up Data
25%
Gastrointestinal Hemorrhage
25%
High Incidence
25%
Hyperglycemia
25%
Hypertension Incidence
25%
Increased Incidence
100%
Intraventricular Hemorrhage
25%
Logistic Regression Analysis
25%
Long-term Neurodevelopmental Outcomes
25%
Most Common Form
25%
Neonatal Course
25%
Neonatal Morbidity
25%
Neonatal Period
50%
Neurological Outcome
25%
Odds Ratio
75%
Periventricular Leukomalacia
50%
Placebo
100%
Placebo Groups
25%
Preterm Infants
50%
Randomized Double-blind Placebo-controlled Study
25%
Respiratory Distress Syndrome
50%
Significant Predictors
25%
Spastic Diplegia
25%
Steroid Administration
25%
Surfactant Treatment
25%
Survivors
25%
Treatment Efficacy
100%
Treatment for Prevention
25%
Ultrasound Scan
25%
Nursing and Health Professions
Antenatal Steroid
9%
Brain Hemorrhage
9%
Cerebral Palsy
100%
Chronic Lung Disease
18%
Confidence Interval
27%
Developmental Delay
18%
Dexamethasone
100%
Disease
9%
Encephalomalacia
18%
Gastrointestinal Hemorrhage
9%
Hyperglycemia
9%
Logistic Regression Analysis
9%
Newborn Morbidity
9%
Odds Ratio
27%
Placebo
45%
Placebo-Controlled Study
9%
Respiratory Distress Syndrome
18%
Sodium Chloride
9%
Sodium Thiopental
9%
Surfactant
9%
Medicine and Dentistry
Antenatal Steroid
9%
Bleeding
9%
Childbirth
9%
Chronic Lung Disease
18%
Developmental Delay
18%
Dexamethasone
100%
Disease
9%
Encephalomalacia
18%
Gastrointestinal Bleeding
9%
Hyperglycemia
9%
Logistic Regression Analysis
9%
Newborn Morbidity
9%
Newborn Period
18%
Odds Ratio
27%
Placebo
45%
Placebo-Controlled Study
9%
Respiratory Distress Syndrome
18%
Sodium Chloride
9%
Spastic Diplegia
100%
Surfactant
9%
Thiopental
9%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Hemorrhage
9%
Cerebral Palsy
100%
Chronic Lung Disease
18%
Developmental Delay
18%
Dexamethasone
100%
Disease
9%
Encephalomalacia
18%
Gastrointestinal Hemorrhage
9%
Hyperglycemia
9%
Newborn Morbidity
9%
Placebo
45%
Placebo-Controlled Study
9%
Respiratory Distress Syndrome
18%
Sodium Chloride
9%
Sodium Thiopental
9%
Surfactant
9%
Neuroscience
Antenatal Steroid
9%
Cerebral Palsy
100%
Dexamethasone
100%
Distress Syndrome
18%
Hyperglycemia
9%
Placebo
54%
Sodium Thiopental
9%
Surfactant
9%